ASCO Post-Conference Report

28 July 2017

This report is a collection of BPI’s articles related to our attendance of the 2017 ASCO (American Society of Clinical Oncology) conference. It includes coverage based on our discussions with key opinion leaders about how the most important information coming out of the meeting will impact the drug development sector. It also includes trends and intel that the investigative journalist team gathered during the conference.

Companies mentioned in the report include Roche, Bristol-Myers Squibb, AstraZeneca, Incyte, Pfizer, Abbvie, bluebird and more.